These results suggest that the impact of KSR2 on atherosclerosis is multifaceted, the development of KSR2-specific activators may offer a promising therapeutic approach for treating atherosclerosis-related diseases in clinical practice. This evidence concerns the gene KSR2 and atherosclerosis.